Bharat Serums AND Vaccines Limited Folic Export Data — India (DGFT 2022–2026)

Name: Bharat Serums AND Vaccines Limited Folic Export Records India — #9 Exporter, 78 Shipments, $1.3M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Folic

India Pharmaceutical Trade Intelligence

$56.1M693 Suppliers148 CountriesHS 30049099

ExportsIndia → FRANCE15.7%India → ANGOLA7.5%

ImportsSWITZERLAND → India$48.5K UNITED KINGDOM → India$2.6K

#1 Supplier: UMAVIDA PHARMA #1 Buyer: PRINCE FARMA,

Bharat Serums AND Vaccines Limited — Folic Exporter #9 | $1.3M Trade Value | TransData Nexus | TransData Nexus

Bharat Serums AND Vaccines Limited — Folic Exporter Profile

Indian Pharmaceutical Exporter · #9 for Folic · $1.3M export value · DGFT Verified

Bharat Serums AND Vaccines Limited is the #9 Indian exporter of Folic with $1.3M in export value and 78 verified shipments. Bharat Serums AND Vaccines Limited holds a 2.4% market share in Folic exports across 11 countries. The company exports 4 pharmaceutical products worth $40.1M across 3 therapeutic categories.

Bharat Serums AND Vaccines Limited — Folic Export Profile: Buyers & Destinations

Bharat Serums AND Vaccines Limited Folic export treemap — buyers and destination countries | TransData Nexus

Where Does Bharat Serums AND Vaccines Limited Export Folic?

Country	Value	Shipments	Share
MALAYSIA	$491.1K	15	41.3%
IRAQ	$369.6K	8	31.1%
PHILIPPINES	$113.4K	8	9.5%
ZIMBABWE	$66.0K	7	5.5%
NIGERIA	$54.6K

Who Are the Top Buyers of Folic from Bharat Serums AND Vaccines Limited?

Buyer	Country	Value	Orders
HIGEN COMPANY	IRAQ	$369.6K	8
TO CIMB ISLAMIC BANK	MALAYSIA	$123.9K	3
BSV BIOSCIENCE MALAYSIA SDN BHD	MALAYSIA	$111.1K	6
FIRST LINE PHARMACEUTICALS SDN BHD	MALAYSIA	$89.6K	2
FIRSTLINE PHARMACEUTICALS SDN	MALAYSIA	$76.8K	2
CHANRAI HEALTHCARE LTD,	NIGERIA	$54.6K	2
BSV BIOSCIENCE PHILIPPINES INC.	PHILIPPINES	$53.3K	4
FIRSTLINE PHARMACEUTICALS SDN BHD	MALAYSIA	$50.0K	1
TO CIMB ISLAMIC BANK BERHAD (671380	MALAYSIA	$39.6K	1
BSV BIOSCIENCE PHILS INC	PHILIPPINES	$27.2K	1

Bharat Serums AND Vaccines Limited supplies Folic to 30 buyers globally. The largest buyer is HIGEN COMPANY (IRAQ), followed by TO CIMB ISLAMIC BANK (MALAYSIA) and BSV BIOSCIENCE MALAYSIA SDN BHD (MALAYSIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Folic Formulations Does Bharat Serums AND Vaccines Limited Export?

Product Description / Formulation	Value	Shipments
FOLICULIN 150 IU [UROFOLLITROPIN FOR INJ	$123.9K	3
FOLICULIN 75 IU HP [Urofollitropin for I	$119.6K	3
FOLICULIN 75 IU HP UROFOLLITROPIN FOR INJECTION B.P. FREEZE DRIED (HIGHLY PURIFIED)	$100.0K	2
FOLICULIN 75 IU [Urofollitropin for Inje	$82.0K	3
FOLICULIN 75 IU HP [UROFOLLITROPIN FOR I	$50.0K	1
FOLICULIN 150 IU UROFOLLITROPIN FOR INJE	$50.0K	1
FOLICULIN 150 IU [Urofollitropin for Inj	$50.0K	1
FOLICULIN 75 IU HP [Urofollitropin for Injection B.P.] [Freeze Dried Highly Purified	$50.0K	1
FOLICULIN 150 IU [UROFOLLITROPIN FOR INJECTION B.P.] - FREEZE DRIED	$50.0K	1
FOLICULIN 75 IU HP UROFOLLITROPIN FOR INJECTION B P FREEZE DRIED HIGHLY PURIFIED 25000 VLS	$50.0K	1

Bharat Serums AND Vaccines Limited exports 51 distinct Folic formulations including tablets, capsules, syrups, and combination drugs. The top formulation is FOLICULIN 150 IU [UROFOLLITROPIN FOR INJ with 3 shipments worth $123.9K.

How Does Bharat Serums AND Vaccines Limited Compare to Nearest Folic Exporters?

Exporters ranked immediately above and below #9 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
5	MEDICAMEN BIOTECH LIMITED	$2.0M	41	13	$50.0K
8	MICRO LABS LIMITED	$1.6M	79	12	$20.0K
9	BHARAT SERUMS AND VACCINES LIMITED ★	$1.3M	78	11	$17.1K
1	UMAVIDA PHARMA PRIVATE LIMITED	$1.1M	23	1	$50.0K
11	SIDHAANT LIFE SCIENCES PRIVATE LIMITED	$1.0M	23	5	$45.5K

Bharat Serums AND Vaccines Limited ranks #9 among 693 Indian Folic exporters. Average shipment value of $17.1K compared to the market average of $32.3K. The closest competitors by value are MEDICAMEN BIOTECH LIMITED and MICRO LABS LIMITED.

Which Indian Ports Ship Folic Exports?

Port	Shipments	% Share
NHAVA SHEVA SEA (INNSA1)	679	12.7%
JNPT	390	7.3%
JNPT/ NHAVA SHEVA SEA	348	6.5%
SAHAR AIR	334	6.2%
SAHAR AIR CARGO ACC (INBOM4)	284	5.3%
MUNDRA SEA	184	3.4%
DELHI AIR	158	2.9%
PATLI ICD	153	2.9%

Geopolitical & Trade Policy Impact on Bharat Serums AND Vaccines Limited's Folic Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like BSV. Heightened security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor have led major carriers to alter trade routes, resulting in extended transit times and increased freight rates on key India–Europe shipping lanes. These disruptions can impact the timely delivery of pharmaceutical products, potentially affecting supply chains and customer relationships. (livemint.com)

Conversely, the India–European Union Free Trade Agreement, concluded in January 2026, is poised to eliminate tariffs on Indian pharmaceutical exports to the EU. This development enhances the competitiveness of Indian exporters like BSV in the European market, potentially offsetting some of the logistical challenges posed by current shipping disruptions. (en.wikipedia.org)

Additionally, ongoing US-China trade tensions have prompted the United States to diversify its pharmaceutical supply chain, creating opportunities for Indian manufacturers to increase their market share in the US. BSV's established presence in critical care and biologics positions it well to capitalize on this shift.

Bharat Serums AND Vaccines Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards is paramount for pharmaceutical exporters. BSV's adherence to stringent quality requirements, including FDA, WHO, and EU GMP standards, has been instrumental in maintaining its export credentials. The company's focus on high-entry-barrier products necessitates continuous investment in quality assurance and regulatory compliance to meet the evolving standards of global markets.

The recent acquisition by Mankind Pharma is expected to bolster BSV's compliance infrastructure, leveraging Mankind's resources to enhance quality systems and ensure sustained adherence to international regulatory expectations.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Folic shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Bharat Serums AND Vaccines Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 78 individual customs records matching Bharat Serums AND Vaccines Limited exporting Folic, covering 51 formulations to 11 countries via 30 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 148+ countries, 1,433+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Folic

Folic

Bharat Serums AND Vaccines Limited — Folic Exporter Profile

Bharat Serums AND Vaccines Limited — Folic Export Profile: Buyers & Destinations

Where Does Bharat Serums AND Vaccines Limited Export Folic?

Who Are the Top Buyers of Folic from Bharat Serums AND Vaccines Limited?

What Is India's Total Folic Export Value and How Much Does Bharat Serums AND Vaccines Limited Contribute?

What Is the Average Shipment Value for Bharat Serums AND Vaccines Limited's Folic Exports?

How Does Bharat Serums AND Vaccines Limited Compare to Other Indian Folic Exporters?

What Folic Formulations Does Bharat Serums AND Vaccines Limited Export?

How Does Bharat Serums AND Vaccines Limited Compare to Nearest Folic Exporters?

Which Indian Ports Ship Folic Exports?

Geopolitical & Trade Policy Impact on Bharat Serums AND Vaccines Limited's Folic Exports

Bharat Serums AND Vaccines Limited — Regulatory Compliance & Quality Standards

About Bharat Serums AND Vaccines Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Folic Export Data from Bharat Serums AND Vaccines Limited

Folic Stats

Company Overview

Top Products by Bharat Serums AND Vaccines Limited

Related Analysis

Need Detailed Export Data?

Data Source